Day Lucy is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $9K.
Profile
Lucy Day is listed as the Chief Financial Officer of AN2 Therapeutics, Inc. in the SEC filing dated 2026-01-08. AN2 Therapeutics is a small biopharmaceutical company with a focus on boron-based small molecule therapeutics for infectious diseases and oncology, and the firm has a 36-employee team. The filing indicates Day had total purchases and total sales of $0, suggesting no reported insider trading activity in that filing period.
Lucy Day is listed as the Chief Financial Officer of AN2 Therapeutics, Inc. in the SEC filing dated 2026-01-08. AN2 Therapeutics is a small biopharmaceutical company with a focus on boron-based small molecule therapeutics for infectious diseases and oncology, and the firm has a 36-employee team. The filing indicates Day had total purchases and total sales of $0, suggesting no r…
Has Day Lucy been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($9K) across all tracked filings.
Where can I see all of Day Lucy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
